Kimberly Gorode News Today

Simple blood tests for Alzheimer's disease have hit the market, representing a potentially powerful tool to help diagnose the devastating illness. But the tests are stirring debate on scientific and ethical questions.

Alzheimer's is frequently misdiagnosed, especially in the early stages

Lawmakers on Capitol Hill scrambled Monday to finalize and pass a $10 billion COVID-19 response package that will likely be less than half the amount that President Biden demanded.

The wind-down of the uninsured program is among the first concrete casualties of a decision by Congress this month to exclude about $15 billion in pandemic relief from a large spending plan adopted for other parts of the government and the Ukraine war.

Originally published on January 27, 2021 6:19 am It’s going to take about a week for the state’s lab to answer an urgent question. “Can we take some more proactive and aggressive action [against the more contagious COVID-19 variant] and really control these clusters that were currently seeing?” Susan Ringler-Cerniglia, a Washtenaw County Health Department spokesperson, said Monday. “Or is, in fact, the variant already circulating more than weve detected?” The answer may depend on ...

How will labs use expanded molecular testing capacities post-COVID-19? Adam Bonislawski, GenomeWeb Print With COVID-19 vaccinations beginning this week in the US, the country is entering a new stage of the pandemic that could ultimately end in widespread suppression of the virus. The implications of this development for the lab industry are not entirely clear, but after almost a year spent building out molecular capacities to meet COVID-19 test demand, the question of what to do with that cap...